Literature DB >> 33385690

Impulsivity and craving in subjects with opioid use disorder on methadone maintenance treatment.

Jun Li1, Kathrin Weidacker2, Alekhya Mandali2, Yingying Zhang1, Seb Whiteford2, Qihuan Ren3, Zhirong Zhou4, Huijing Zhou5, Haifeng Jiang6, Jiang Du6, Chencheng Zhang1, Bomin Sun7, Valerie Voon8.   

Abstract

BACKGROUND: Methadone maintenance treatment (MMT) is effective in decreasing opioid use or facilitating abstinence. Previous studies using small opioid use disorder samples suggest that cognitive impairments including impulsivity and executive functions may partially improve on MMT, but a range of deficits may persist. However, systematic assessments with larger samples are needed to confirm the profile of cognitive functions on MMT.
METHODS: We assessed four types of impulsivity (delay discounting, reflection impulsivity, risk taking and motoric impulsivity), executive functioning (spatial working memory, paired associative learning and strategic planning) and drug cue-induced craving in a relatively large population (115 MMT patients, 115 healthy controls). The relationships between impulsivity, drug cue-induced craving and addiction-related variables were also assessed.
RESULTS: Delay discounting, as well as drug cue-induced craving was increased in patients, while motoric impulsivity was lower than in controls. Paired associative learning was additionally impaired, which was explained by increased depression and anxiety levels in patients. Within the MMT group, the delay discounting and drug-cue induced craving scores were positively correlated with self-reported urgency, but unrelated to methadone dosage, duration on methadone, withdrawal symptoms, or presence of nicotine dependence.
CONCLUSIONS: Our findings highlight increased delay discounting and cue-induced craving in MMT patients suggesting a potential role for trait effects in delay discounting. Although previous smaller studies have shown impaired executive function, in our large sample size on chronic MMT we only observed impaired associative learning related to depressive and anxiety symptoms highlighting a role for managing comorbid symptoms to further optimize cognitive function.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Drug craving; Executive function; Impulsivity; Methadone

Year:  2020        PMID: 33385690     DOI: 10.1016/j.drugalcdep.2020.108483

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  5 in total

1.  Modulation of Attentional Bias to Drug and Affective Cues by Therapeutic and Neuropsychological Factors in Patients With Opioid Use Disorder on Methadone Maintenance Therapy.

Authors:  Wenhui Li; Jin Huang; Nan Zhang; Kathrin Weidacker; Jun Li; Valerie Voon; Chuansheng Wang; Chencheng Zhang
Journal:  Front Psychiatry       Date:  2022-01-12       Impact factor: 4.157

2.  Psychosocial Factors Predict the Level of Substance Craving of People with Drug Addiction: A Machine Learning Approach.

Authors:  Hua Gong; Chuyin Xie; Chengfu Yu; Nan Sun; Hong Lu; Ying Xie
Journal:  Int J Environ Res Public Health       Date:  2021-11-19       Impact factor: 3.390

3.  Impulsivity Relates to Multi-Trial Choice Strategy in Probabilistic Reversal Learning.

Authors:  Amy R Zou; Daniela E Muñoz Lopez; Sheri L Johnson; Anne G E Collins
Journal:  Front Psychiatry       Date:  2022-03-14       Impact factor: 4.157

4.  High-frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may reduce impulsivity in patients with methamphetamine use disorders: A pilot study.

Authors:  Qingming Liu; Xingjun Xu; Huimin Cui; Lei Zhang; Zhiyong Zhao; Da Dong; Ying Shen
Journal:  Front Hum Neurosci       Date:  2022-08-05       Impact factor: 3.473

5.  Frontal Lobe Functions, Demoralization, Depression and Craving as Prognostic Factors and Positive Outcomes of Patients with Heroin Use Disorder Receiving 6 Months of Methadone Maintenance Treatment.

Authors:  Ting-Gang Chang; Ting-Ting Yen; Wen-Yu Hsu; Shan-Mei Chang
Journal:  Int J Environ Res Public Health       Date:  2022-03-20       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.